VSCI Stock Quote and Technical Analysis
| Portfolios | Markets | Resources |
|
|
|
Vision-Sciences, Inc. (VSCI) ► 1.09 (0.00) Open: N/A High: N/A Low: N/A Afterhours: N/A - N/A Volume: 0 5/17/2013 3:59pm |
Interactive Chart |
| EPS: -0.23 (Current Year Estimated: -0.21) Dividend: N/A P/E: N/A Technicals: 52 Week Range: 0.91 - 1.70 50 Day Moving Average: 1.0775 200 Day Moving Average: 1.1217 Pivot Point: Not Available Login or signup free to Add "VSCI" to your portfolio Resources: |
| News: VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers Thu, 16 May 2013 14:25:07 GMT VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ Wed, 15 May 2013 03:08:33 GMT Vision Sciences appoints Howard Zauberman as interim CEO Mon, 13 May 2013 21:10:52 GMT Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer Mon, 13 May 2013 21:01:49 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that Howard ... Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript Tue, 30 Apr 2013 14:19:04 GMT [at Seeking Alpha] - Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Tue, 30 Apr 2013 03:20:57 GMT Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 Mon, 29 Apr 2013 22:10:06 GMT [at noodls] - April 29, 2013 Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. ... Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 Mon, 29 Apr 2013 21:30:00 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced financial results ... Q4 2013 Vision Sciences Inc Earnings Release - After Market Close Mon, 29 Apr 2013 11:07:06 GMT Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results Tue, 23 Apr 2013 22:06:07 GMT [at noodls] - April 23, 2013 Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading ... Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results Tue, 23 Apr 2013 21:18:56 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company ... Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System Tue, 19 Mar 2013 16:09:38 GMT [at noodls] - March 18, 2013 The 7000 Series Vision System(R) Offers Imaging, Video/Audio Archiving, and Workflow Features in One Platform ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ... Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System Mon, 18 Mar 2013 20:05:00 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced the launch of ... Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors Wed, 13 Mar 2013 14:55:49 GMT [at noodls] - March 12, 2013 ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ... VISION SCIENCES INC /DE/ Files SEC form 8-K, Financial Statements and Exhibits Wed, 13 Mar 2013 12:49:51 GMT Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors Tue, 12 Mar 2013 20:38:44 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that Dr. Cheryl ... Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference Wed, 06 Mar 2013 21:58:05 GMT [at noodls] - March 6, 2013 ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ... Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference Wed, 06 Mar 2013 21:15:00 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that Cynthia ... Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference Thu, 07 Feb 2013 20:22:13 GMT [at noodls] - February 7, 2013 Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ... VISION SCIENCES INC /DE/ Financials Fri, 01 Feb 2013 18:04:24 GMT All Company News is Powered by Yahoo! Finance |
[QUOTE=chipzz;29513]Thanks for your good advice!, very handy. You should do your own business advising people with credit difficulties, many of the services charge a bundle and provide close to no...
687 FICO Score......What Card can...